Excipient exchange in the comparison of preparations of the same biologic made by different manufacturing processes: An exploratory study with recombinant human growth hormone (rhGH)-Reference-Cited by-同舟云学术

Excipient exchange in the comparison of preparations of the same biologic made by different manufacturing processes: An exploratory study with recombinant human growth hormone (rhGH)

Published:2010-11 Issue:6 Volume:38 Page:637-643
ISSN:1045-1056
Container-title:Biologicals
language:en
Short-container-title:Biologicals

Author:

Cauchy Mike,Hefford Mary Alice

Publisher

Elsevier BV

Subject

Pharmacology,General Immunology and Microbiology,Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Reference46 articles.

1. Follow-on biologics: challenges of the “next generation”;Schellekens;Nephrology Dialysis Transplantation,2005

2. Controversial new biologic approved in US;Bouchie;The Scientist,2006

3. Clinical comparability and European biosimilar regulations;Schellekens;Nature Biotechnology,2010

4. Are biosimilars really generics?;Misra;Expert Opinion on Biological Therapy,2000

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein comparability assessments and potential applicability of high throughput biophysical methods and data visualization tools to compare physical stability profiles;Frontiers in Pharmacology;2014-03-12

2. Analytical lessons learned from selected therapeutic protein drug comparability studies;Biologicals;2013-05

3. Utility of standard pharmacopeial and nonpharmacopeial methods in distinguishing folded, unfolded, and process variant forms of interferon α-2;Journal of Pharmaceutical Sciences;2012-10

4. Protein–excipient interactions: Mechanisms and biophysical characterization applied to protein formulation development;Advanced Drug Delivery Reviews;2011-10